Literature DB >> 990183

Inhibitor of stem cell proliferation in normal bone marrow.

B I Lord, K J Mori, E G Wright, L G Lajtha.   

Abstract

A saline extract from normal bone marrow cells having a molecular weight in the range 50000-1000000 daltons has been found to protect rapidly proliferating haemopoietic spleen colony forming cells (CFUs) from the lethal effects of large doses of tritiated thymidine. This extract is non-toxic to the cells. It is not found in regenerating marrow where the CFUs population is rapidly proliferating. Its effect appears to be specific for the CFUs since it has no effect on the proliferation of its close descendant, the granulocytic precursor cell (CFUc), and no effect on the average cytoplasmic structuredness of the whole bone marrow cell population. The active material is probably protein since it is degraded by trypsin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990183     DOI: 10.1111/j.1365-2141.1976.tb03590.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

Review 1.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

Authors:  M Lenfant; J Wdzieczak-Bakala; E Guittet; J C Prome; D Sotty; E Frindel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Haemopoietic stem cell proliferation: spatial and temporal considerations.

Authors:  E G Wright; B I Lord
Journal:  Br J Cancer Suppl       Date:  1986

4.  A novel in vitro assay for murine haematopoietic stem cells.

Authors:  L Eckmann; M Freshney; E G Wright; A Sproul; N Wilkie; I B Pragnell
Journal:  Br J Cancer Suppl       Date:  1988-12

5.  Inhibition of lymphocyte production via thymic factors.

Authors:  I Blazsek
Journal:  Blut       Date:  1981-04

6.  Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.

Authors:  C S Potten; G Owen; D Hewitt; C A Chadwick; H Hendry; B I Lord; L B Woolford
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  K J Rieger; N Saez-Servent; M P Papet; J Wdzieczak-Bakala; J L Morgat; J Thierry; W Voelter; M Lenfant
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

8.  MIP1 alpha nuclear protein (MNP), a novel transcription factor expressed in hematopoietic cells that is crucial for transcription of the human MIP-1 alpha gene.

Authors:  L M Ritter; M Bryans; O Abdo; V Sharma; N M Wilkie
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

9.  Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

Authors:  J L Spivak; R R Smith; J N Ihle
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.

Authors:  E Marshall; L B Woolford; B I Lord
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.